![Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo -controlled study | npj Aging Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo -controlled study | npj Aging](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41514-017-0016-9/MediaObjects/41514_2017_16_Fig1_HTML.png)
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo -controlled study | npj Aging
![Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-42059-3/MediaObjects/41598_2019_42059_Fig1_HTML.png)
Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports
![Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/086822a5-b0f9-4079-b310-1dbed43508fa/gr1.jpg)
Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus
![Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/c17d2153-ddaa-4c2d-a5f5-e390d6c1e5df/gr1.jpg)
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine
![A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2016-0026/asset/images/medium/figure1.gif)
A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology
Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity | PLOS ONE
![Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial | Journal of Clinical Sleep Medicine Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial | Journal of Clinical Sleep Medicine](https://jcsm.aasm.org/cms/asset/56b24110-db8b-48bb-8f31-4e4ef2bf45a1/jcsm.26591.fp.png)
Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial | Journal of Clinical Sleep Medicine
![Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01861-9/MediaObjects/41591_2022_1861_Fig1_HTML.png)
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine
![The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review](https://hearingreview.com/wp-content/uploads/2017/05/HumesFig1-1000x640.jpg)
The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review
![Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/f4acc1aa-d40f-42f0-b3db-34d878a7c040/gr1.jpg)
Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice
A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation - Food & Function (RSC Publishing)
![3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity 3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity](https://debraireland.org/wp-content/uploads/3-month-randomised-double-blind-placebo-controlled-phase-followed-by-a-24-month-open-label-single-arm-phase.-The-primary-endpoint-of-the-trial-was-to-compare-the-efficiency-4.png)
3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity
![Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/f9b016fe-bd8d-4a93-a587-d4f33837b0e9/gr1.jpg)
Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice
![A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0261561419300822-fx1.jpg)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
![A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820300260-fx1.jpg)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
![A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/cf5e8046-e618-48ed-873e-1879d97e4e5c/gr1.jpg)
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
![Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/49f40097-6e0d-4932-85b8-0be2c505a647/gr1.gif)
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet
![A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation - eClinicalMedicine A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation - eClinicalMedicine](https://www.thelancet.com/cms/attachment/041f3784-ff95-4570-8f70-37483a77ce15/gr1_lrg.jpg)
A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation - eClinicalMedicine
![A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy](https://www.cell.com/cms/attachment/f7119006-e9eb-45cc-a48a-f2878fe07e4a/gr1.jpg)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
![A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody | Alzheimer's Research & Therapy | Full Text A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-021-00813-8/MediaObjects/13195_2021_813_Fig1_HTML.png)